Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $7.4550 (-2.04%) ($7.4550 - $7.4550) on Tue. Jul. 13, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.97% (three month average) | RSI | 50 | Latest Price | $7.4550(-2.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.7% a day on average for past five trading days. | Weekly Trend | CGEN declines -4.6% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(72%) ARKG(70%) ARKK(67%) IWO(66%) ACES(63%) | Factors Impacting CGEN price | CGEN will decline at least -1.985% in a week (0% probabilities). VIXM(-49%) VXX(-38%) UUP(-16%) TLT(-8%) IGOV(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.985% (StdDev 3.97%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-1.8(-124.14%) | Resistance Level | $7.94 | 5 Day Moving Average | $7.56(-1.39%) | 10 Day Moving Average | $7.8(-4.42%) | 20 Day Moving Average | $7.94(-6.11%) | To recent high | -17.9% | To recent low | 8.4% | Market Cap | $616m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |